CHARLOTTE – Taysha Gene Therapies has halted efforts to build out a manufacturing facility in Durham, according to the company’s latest annual report. Taysha is seeking buyers for the site. The move comes more than two years after the biotech announced its plans to invest about $75 million in the facility, which was supposed to employ 200 people.